drug

IMGN632

1 story · latest Sep 4, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by AbbVie

Timeline

AbbVie posts IMGN632 BPDCN results; opens NOA LIFT filler trial vs VOLIFT

Sep 4Weekly roundup, 4 itemsAbbVie IMGN632

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.